Robert Temple

11.1k total citations · 2 hit papers
78 papers, 6.9k citations indexed

About

Robert Temple is a scholar working on Economics and Econometrics, Statistics and Probability and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Robert Temple has authored 78 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Economics and Econometrics, 24 papers in Statistics and Probability and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Robert Temple's work include Health Systems, Economic Evaluations, Quality of Life (30 papers), Statistical Methods in Clinical Trials (23 papers) and Pharmaceutical Economics and Policy (12 papers). Robert Temple is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (30 papers), Statistical Methods in Clinical Trials (23 papers) and Pharmaceutical Economics and Policy (12 papers). Robert Temple collaborates with scholars based in United States, United Kingdom and Canada. Robert Temple's co-authors include Enrico Corazziari, William E. Whitehead, Zhiming Li, N. J. Talley, Joel E. Richter, Peter Funch‐Jensen, Douglas A. Drossman, Gary G. Koch, W. Grant Thompson and Janet Woodcock and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Robert Temple

75 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

U. S. Householder survey of functional gastrointestinal disorders

1993 1.8k citations Robert Temple et al. profile →
Real-World Evidence — What Is It and What Can It Tell Us?

2016 1.3k citations Robert Temple et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Temple United States	32	1.4k	1.3k	946	674	629	78	6.9k
Ron M. C. Herings Netherlands	47	409 0.3×	1.5k 1.1×	717 0.8×	233 0.3×	538 0.9×	247	8.4k
Giovanni Corrao Italy	63	1.1k 0.8×	3.1k 2.4×	1.0k 1.1×	214 0.3×	938 1.5×	419	16.5k
Anton Pottegård Denmark	46	316 0.2×	1.3k 1.0×	944 1.0×	226 0.3×	510 0.8×	385	10.0k
Luis A. Garcı́a Rodrı́guez Spain	65	1.7k 1.2×	4.1k 3.2×	682 0.7×	246 0.4×	1.0k 1.6×	282	15.3k
M. D. Rawlins United Kingdom	45	266 0.2×	1.1k 0.8×	1.3k 1.4×	157 0.2×	629 1.0×	221	8.6k
Lise Lotte Gluud Denmark	54	442 0.3×	4.2k 3.3×	624 0.7×	356 0.5×	1.8k 2.9×	235	15.3k
Nicole Pratt Australia	38	251 0.2×	2.2k 1.7×	763 0.8×	327 0.5×	267 0.4×	214	6.6k
Thomas M. MacDonald United Kingdom	57	276 0.2×	2.6k 2.0×	798 0.8×	132 0.2×	853 1.4×	357	12.9k
Richard A. Hansen United States	39	389 0.3×	638 0.5×	751 0.8×	96 0.1×	443 0.7×	216	6.3k
Morten Andersen Denmark	44	162 0.1×	1.1k 0.9×	898 0.9×	188 0.3×	341 0.5×	211	6.6k

Countries citing papers authored by Robert Temple

Since Specialization

Citations

This map shows the geographic impact of Robert Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Temple more than expected).

Fields of papers citing papers by Robert Temple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Temple. The network helps show where Robert Temple may publish in the future.

Co-authorship network of co-authors of Robert Temple

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Temple. A scholar is included among the top collaborators of Robert Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Temple. Robert Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kempf, Lucas, Jonathan C. Goldsmith, & Robert Temple. (2017). Challenges of developing and conducting clinical trials in rare disorders. American Journal of Medical Genetics Part A. 176(4). 773–783. 110 indexed citations

Farkas, Ronald H., Ellis F. Unger, & Robert Temple. (2013). Zolpidem and Driving Impairment — Identifying Persons at Risk. New England Journal of Medicine. 369(8). 689–691. 84 indexed citations

Khin, Ni A., Pei–Ming Yang, Hung Hung, et al.. (2013). Regulatory and Scientific Issues Regarding Use of Foreign Data in Support of New Drug Applications in the United States: An FDA Perspective. Clinical Pharmacology & Therapeutics. 94(2). 230–242. 25 indexed citations

O’Neill, Robert T. & Robert Temple. (2012). The Prevention and Treatment of Missing Data in Clinical Trials: An FDA Perspective on the Importance of Dealing With It. Clinical Pharmacology & Therapeutics. 91(3). 550–554. 103 indexed citations

Sm, Huang, Hong Zhao, Ji Lee, et al.. (2010). Therapeutic Protein–Drug Interactions and Implications for Drug Development. Clinical Pharmacology & Therapeutics. 87(4). 497–503. 93 indexed citations

Temple, Robert. (2008). Complexities in Drug Trials: Enrichment, Biomarkers and Surrogates. Biomarkers in Medicine. 2(2). 109–112. 3 indexed citations

Temple, Robert & Norman Stockbridge. (2007). BiDil for Heart Failure in Black Patients: The U.S. Food and Drug Administration Perspective. Annals of Internal Medicine. 146(1). 57–62. 61 indexed citations

Koerner, John, et al.. (2006). OIII-A-1FDA evaluation of cardiac repolarization data for 19 drugs and drug candidates. Clinical Pharmacology & Therapeutics. 79(2). P29–P29. 7 indexed citations

Brown, Clarice, Matthew G. Sampson, Rosemary Greenwood, P. J. Heyburn, & Robert Temple. (2003). Acromegaly: A study of epidemiological characteristics and treatment outcomes. 5. 1 indexed citations

10.

Rothmann, Mark D., Ning Li, Gang Chen, et al.. (2002). Design and analysis of non‐inferiority mortality trials in oncology. Statistics in Medicine. 22(2). 239–264. 179 indexed citations

11.

Temple, Robert. (2002). Policy developments in regulatory approval. Statistics in Medicine. 21(19). 2939–2948. 23 indexed citations

12.

Martin, Una, Robert Temple, Gopalakrishnan Venkat‐Raman, & L. F. Prescott. (2002). Paracetamol disposition in renal allograft recipients. European Journal of Clinical Pharmacology. 57(12). 853–856. 4 indexed citations

13.

Temple, Robert, et al.. (2001). Editorial. BT Technology Journal. 19(3). 2–3. 1 indexed citations

14.

Temple, Robert. (1999). Role of government agencies regarding cost-effectiveness claims: FDA perspective. American Heart Journal. 137(5). S75–S77. 1 indexed citations

15.

Temple, Robert, et al.. (1995). Women in Clinical Trials: an FDA Perspective. Science. 269(5225). 793–795. 26 indexed citations

16.

Hendeles, Leslie, John K. Jenkins, & Robert Temple. (1995). Revised FDA Labeling Guideline for Theophylline Oral Dosage Forms. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 15(4). 409–427. 22 indexed citations

17.

Temple, Robert, et al.. (1994). Women in clinical trials.. PubMed. 8(6). 52, 57–52, 57. 8 indexed citations

18.

Lietman, Paul S., Robert Temple, Mark Harrington, & Carl C. Peck. (1990). Design of clinical trials—approaches to clinical trials design. JAIDS Journal of Acquired Immune Deficiency Syndromes. 3. 1 indexed citations

19.

Temple, Robert. (1989). Government Viewpoint of Clinical Trials of Cardiovascular Drugs. Medical Clinics of North America. 73(2). 495–509. 15 indexed citations

20.

Blackwell, Barry, Paul D. Stolley, Ralph Buncher, et al.. (1975). Panel 4: Phase IV investigations. Clinical Pharmacology & Therapeutics. 18(5part2). 653–656. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact